SourceBio International plc Acquires LDPath Limited

Roche to Acquire PathAI to Expand AI-Powered Digital Pathology

May 7, 2026

AI & Machine Learning

Roche has entered into a definitive merger agreement to acquire PathAI, a US digital pathology and AI technology company. The deal is expected to close in the second half of the year and will integrate PathAI’s AISight image management system into Roche’s Diagnostics division.

NeoGenomics Acquires Pathline

April 7, 2025

Healthcare Services

NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.

LabGenomics USA LLC Acquires QDx Pathology

September 5, 2023

Healthcare Services

LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.

Lighthouse Lab Services Acquires Pathology Lab Solutions

May 18, 2023

Healthcare Services

Lighthouse Lab Services (LLS) has acquired Pathology Lab Solutions (PLS), a pathology-focused consulting and equipment company that helps physician practices establish in‑office pathology labs. The acquisition expands Lighthouse’s service offering to include pathology-specific lab build, compliance, LIS, and revenue cycle management support for GI and other physician practices.

StatLab Medical Products Acquires CellPath Ltd.

June 8, 2022

Medical Devices

StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.

StageBio Acquires TPL Path Labs

October 21, 2020

Healthcare Services

StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.